IDH1 mutation and ATRX loss: Among seven patients with diffuse astrocytomas who had testing for IDH1 mutations performed on paired surgical specimens, two (29%) patients tested positive at diagnosis and remained positive at recurrence. Here, ATRX is linked to diffuse astrocytoma.